HopeStage
Back to all studies
RecruitingNCT06982820

Self-guided brain stimulation for depression with loss of interest

About this titleRead the official source — NCT06982820
Device studyAges 22–75United States + Israel
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 75 years.

Listed locations
Providence and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
170
Sponsor
GrayMatters Health Ltd.
Sponsor type
Other organization
Study type
Device
Intervention type
Device
Locations
United States, Israel
Age range
From 22 Years to 75 Years
Official registry ID
NCT06982820
Official title
Show the full official title

A Prospective, Randomized, Double-blind, Controlled Study to Produce Guidelines for Integrating Prism for MDD Therapy (Reward System [RS] Upregulation) and to Demonstrate Its Superiority Over Sham Therapy

Recruitment & locations

Currently recruiting

Providence, United States · Houston, United States · Ramat Gan, Israel

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is GrayMatters Health Ltd.

Who can participate?

Listed age limits: 22 years to 75 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies